Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis

doi:10.1016/j.amjoto.2018.10.013

American Journal of Otolaryngology

Volume 40, Issue 2, March–April 2019, Pages 297-305

https://doi.org/10.1016/j.amjoto.2018.10.013 Get rights and content

Abstract

Objective

The purpose of the current study was to investigate the diagnostic performance of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) or positron emission tomography/computed tomography (PET/CT) for the detection of cervical lymph node (LN) metastasis in clinically node negative head and neck squamous cell cancer (cN0 HNSCC) patients through a systematic review and meta-analysis.

Methods

The PubMed and EMBASE database, from the earliest available date of indexing through April 30, 2018, were searched for studies evaluating the diagnostic performance of F-18 FDG PET or PET/CT for the detection of LN metastasis in cN0 HNSCC patients. We determined the sensitivities and specificities across studies, calculated positive and negative likelihood ratios (LR+ and LR−), and constructed summary receiver operating characteristic (SROC) curves.

Results

Across 18 studies (1044 patients), the pooled sensitivity for F-18 FDG PET or PET/CT for the detection of LN metastasis was 0.58 and a pooled specificity of 0.87 for patient based analysis. Neck side based analysis showed the pooled sensitivity of 0.67 and a pooled specificity of 0.85. Level based study demonstrated the pooled sensitivity of 0.53 and a pooled specificity of 0.97 (95% CI; 0.95–0.98). In meta-regression analysis, no definite variable was the source of the study heterogeneity.

Conclusion

Introduction

Head and neck squamous cell carcinoma (HNSCC) is the eighth most common malignancy in male in the United States [1]. In 2018, an estimated 37,160 men will be diagnosed with HNSCC [1]. The presence of cervical lymph node (LN) metastasis is one of the most important prognostic factors in HNSCC and has a great impact on patient's treatment and prognosis [2]. Therefore, it is great important to know the exact status of cervical LN involvement of HNSCC to provide the effective treatment.

Generally, clinical examination such as neck palpation, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography (US) with US guided fine needle aspiration cytology (FNAC) are commonly used for cervical LN staging. However, the detection of occult LN metastasis in clinically node negative (cN0) HNSCC patients remains a diagnostic challenge. The prevalence of occult cervical LN metastasis is known to range from 12% to 50% depending on the location and the size of the primary cancer [3,4]. Also, the presence of occult metastasis increases the risk of recurrence and possess the poor prognosis [5].

Currently, the treatment of cN0 HNSCC remains controversial. Although previous study suggested improved survival rates in patients who receive elective neck dissection [6], the treatment is usually determined by the possibility of cervical LN metastasis. Therefore, elective neck dissection should be performed if the risk of occult metastasis is thought to be >15% to 20%.

The CT and MRI are generally used to assess the primary tumor and LN status in HNSCC patients. However, these imaging techniques have low accuracy for confirmation of the absence of cervical LN metastasis and relatively high rate of false positives [7]. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is used to detect cervical LN metastasis in HNSCC patients more accurately than CT and MRI [8,9]. Several previous studies have been published promising role of F-18 FDG PET for the evaluation of cN0 oral cancer patients [10,11]. However, some other studies reported the limited role of F-18 FDG PET/CT for detection of LN metastasis in cN0 cancer patients [12,13].

The purpose of our study is to meta-analyze the published data on the diagnostic accuracy of F-18 FDG PET or PET/CT for the detection of LN metastasis in cN0 HNSCC patients, in order to provide more evidence-based data and to address further studies in the detection of cervical LN metastasis in cN0 HNSCC patients.

Section snippets

Data sources and search strategy

We conducted electronic English-language literature searches of PubMed and Embase database from the earliest available date of indexing through April 30, 2018. We also hand-searched the reference lists of identified publications for additional studies. We used a search algorithm based on a combination of terms: (1) “PET” OR “positron emission tomography” OR “positron emission tomography/computed tomography” OR “PET/CT” “positron emission tomography-computed tomography” OR “PET-CT”; OR “FDG” and

Literature search and selection of studies

After the comprehensive computerized search was performed and references lists were extensively cross-checked, our research yielded 1435 records, of which 347 records of duplicated abstracts were excluded after reviewing the title and abstract. Also, non-relevant 641 studies, 73 case reports, 89 conference abstracts, 27 letters, 16 editorials, and 217 review articles were excluded. Remaining 25 full text articles were assessed for eligibility and 7 articles were excluded due to insufficient

Discussion

In patients with cN0 HNSCC patients, treatment options have been determined by considering the probability of cervical LN metastasis. It is generally accepted that a watchful waiting should be considered when the risk of occult cervical LN metastases is estimated to be 20% or less [41]. If the risk of occult cervical LN metastasis is thought to be >15–20%, elective neck treatment such as selective neck dissection or irradiation should be considered as a standard treatment [41,42]. Neck

Conclusion

The current meta-analysis showed the low sensitivity and moderate specificity of F-18 FDG PET/CT for the detection of cervical LN metastasis in cN0 HNSCC patients. Level based analysis of F-18 FDG PET or PET/CT has a high specificity and NPV for the detection of cervical metastatic LN detection. At present, the literature regarding the use of F-18 FDG PET or PET/CT for this purpose remains still limited; thus, further large multicenter studies would be necessary to substantiate the diagnostic

Declaration of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this study.

Funding information

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Ethical approval

Institutional review board approval was not required because we only performed data analysis based on the published studies.

Informed consent

Written informed consent was not required for this study because it is a meta-analysis based on the studies that have been published.

References (49)

P. Zbären
Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks
Am J Surg
(2006)
J. Kligerman
Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity
Am J Surg
(1994)
A.S. Glas
The diagnostic odds ratio: a single indicator of test performance
J Clin Epidemiol
(2003)
J.J. Deeks et al.
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
J Clin Epidemiol
(2005)
T.H. Hamza et al.
The binomial distribution of meta-analysis was preferred to model within-study variability
J Clin Epidemiol
(2008)
J.B. Reitsma
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
J Clin Epidemiol
(2005)
A. Chauhan
Comparison of PET/CT with conventional imaging modalities (USG, CECT) in evaluation of N0 neck in head and neck squamous cell carcinoma
Med J Armed Forces India
(2012)
C.A. Krabbe
FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases
Oral Oncol
(2008)
C. Nahmias
Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer
J Oral Maxillofac Surg
(2007)
H. Zhang
Utility of PET-CT in detecting nodal metastasis in cN0 early stage oral cavity squamous cell carcinoma
Oral Oncol
(2018)

M.W. van den Brekel et al.

Diagnostic evaluation of the neck

Otolaryngol Clin N Am

(1998)

R.P. Takes

The value of ultrasound with ultrasound-guided fine needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck

Int J Radiat Oncol Biol Phys

(1998)

N.C. Hyde

A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography

Oral Oncol

(2003)

R.L. Siegel et al.

Cancer statistics, 2018

CA Cancer J Clin

(2018)

C.R. Leemans

Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma

Cancer

(1993)

M.W. van den Brekel

The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections

Laryngoscope

(1996)

K.J. Haddadin

Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection

Head Neck

(1999)

J.A. Castelijns et al.

Imaging of lymphadenopathy in the neck

Eur Radiol

(2002)

M.P. Stokkel

Preoperative evaluation of patients with primary head and neck cancer using dual-head ¹⁸fluorodeoxyglucose positron emission tomography

Ann Surg

(2000)

Y. Yamazaki

Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer

Ann Nucl Med

(2008)

S.H. Ng

¹⁸F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation

J Nucl Med

(2005)

F.J. Civantos

Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry

Head Neck

(2003)

L.J. Liao

Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities

BMC Cancer

(2012)

C.T. Liao

PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity

J Nucl Med

(2011)

Cited by (36)

Quarter Century Positron Emission Tomography/Computed Tomography Transformation of Oncology: Head and Neck Cancer
2024, PET Clinics
Obturating the Maxillary Defect: Surgical and Prosthetic Considerations
2024, Atlas of the Oral and Maxillofacial Surgery Clinics of North America
Comparing three-dimensional and two-dimensional deep-learning, radiomics, and fusion models for predicting occult lymph node metastasis in laryngeal squamous cell carcinoma based on CT imaging: a multicentre, retrospective, diagnostic study
2024, eClinicalMedicine
The occult lymph node metastasis (LNM) of laryngeal squamous cell carcinoma (LSCC) affects the treatment and prognosis of patients. This study aimed to comprehensively compare the performance of the three-dimensional and two-dimensional deep learning models, radiomics model, and the fusion models for predicting occult LNM in LSCC.
In this retrospective diagnostic study, a total of 553 patients with clinical N0 stage LSCC, who underwent surgical treatment without distant metastasis and multiple primary cancers, were consecutively enrolled from four Chinese medical centres between January 01, 2016 and December 30, 2020. The participant data were manually retrieved from medical records, imaging databases, and pathology reports. The study cohort was divided into a training set (n = 300), an internal test set (n = 89), and two external test sets (n = 120 and 44, respectively). The three-dimensional deep learning (3D DL), two-dimensional deep learning (2D DL), and radiomics model were developed using CT images of the primary tumor. The clinical model was constructed based on clinical and radiological features. Two fusion strategies were utilized to develop the fusion model: the feature-based DLRad_FB model and the decision-based DLRad_DB model. The discriminative ability and correlation of 3D DL, 2D DL and radiomics features were analysed comprehensively. The performances of the predictive models were evaluated based on the pathological diagnosis.
The 3D DL features had superior discriminative ability and lower internal redundancy compared to 2D DL and radiomics features. The DLRad_DB model achieved the highest AUC (0.89–0.90) among all the study sets, significantly outperforming the clinical model (AUC = 0.73–0.78, P = 0.0001–0.042, Delong test). Compared to the DLRad_DB model, the AUC values for the DLRad_FB, 3D DL, 2D DL, and radiomics models were 0.82–0.84 (P = 0.025–0.46), 0.86–0.89 (P = 0.75–0.97), 0.83–0.86 (P = 0.029–0.66), and 0.79–0.82 (P = 0.0072–0.10), respectively in the study sets. Additionally, the DLRad_DB model exhibited the best sensitivity (82–88%) and specificity (79–85%) in the test sets.
The decision-based fusion model DLRad_DB, which combines 3D DL, 2D DL, radiomics, and clinical data, can be utilized to predict occult LNM in LSCC. This has the potential to minimize unnecessary lymph node dissection and prophylactic radiotherapy in patients with cN0 disease.
National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer
2023, Journal of the American College of Radiology
Imaging of head and neck cancer at initial staging and as part of post-treatment surveillance is a key component of patient care as it guides treatment strategy and aids determination of prognosis. Head and neck cancer includes a heterogenous group of malignancies encompassing several anatomic sites and histologies, with squamous cell carcinoma the most common. Together this comprises the seventh most common cancer worldwide. At initial staging comprehensive imaging delineating the anatomic extent of the primary site, while also assessing the nodal involvement of the neck is necessary. The treatment of head and neck cancer often includes a combination of surgery, radiation, and chemotherapy. Post-treatment imaging is tailored for the evaluation of treatment response and early detection of local, locoregional, and distant recurrent tumor. Cross-sectional imaging with CT or MRI is recommended for the detailed anatomic delineation of the primary site. PET/CT provides complementary metabolic information and can map systemic involvement.
The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Imaging of Neck Nodes in Head and Neck Cancers – a Comprehensive Update
2023, Clinical Oncology
Cervical lymph node metastases from head and neck squamous cell cancers significantly reduce disease-free survival and worsen overall prognosis and, hence, deserve more aggressive management and follow-up. As per the eighth edition of the American Joint Committee on Cancer staging manual, extranodal extension, especially in human papillomavirus-negative cancers, has been incorporated in staging as it is important in deciding management and significantly impacts the outcome of head and neck squamous cell cancer. Lymph node imaging with various radiological modalities, including ultrasound, computed tomography and magnetic resonance imaging, has been widely used, not only to demonstrate nodal involvement but also for guided histopathological evaluation and therapeutic intervention. Computed tomography and magnetic resonance imaging, together with positron emission tomography, are used widely for the follow-up of treated patients. Finally, there is an emerging role for artificial intelligence in neck node imaging that has shown promising results, increasing the accuracy of detection of nodal involvement, especially normal-appearing nodes. The aim of this review is to provide a comprehensive overview of the diagnosis and management of involved neck nodes with a focus on sentinel node anatomy, pathogenesis, imaging correlates (including radiogenomics and artificial intelligence) and the role of image-guided interventions.
Sentinel node biopsy in node negative early oral cancers: Solution to the conundrum!
2022, Oral Oncology
Ideal management of the node-negative neck in early oral cancers is a debated issue. Elective neck dissection (END) is recommended in these patients as it offers a survival benefit. However, about 50–70% of patients who do not harbor occult metastasis are overtreated with this approach. Surgery is associated with morbidity, predominantly shoulder dysfunction. Numerous attempts have been made to identify true node-negative patients through imaging and prediction models but none have high diagnostic accuracy to safely spare the neck dissection. The recent publications of 2 large randomized controlled trials comparing the outcomes of sentinel node biopsy (SNB) and END have spurred interest in SNB. Both the trials reported SNB to be an oncologically safe procedure and spared unnecessary neck dissections. The functional outcomes of the trials showed that SNB limits the morbidity compared to END, which albeit evens out at the end of one-year post-surgery. Despite its benefits, SNB has failed to gain widespread acceptability due to various limitations including the need for infrastructure, equipment costs, staff, and multidisciplinary collaboration of nuclear medicine, surgical, and pathology fraternity. The labor-intensive pathology protocol with serial step sectioning and immunohistochemistry poses a challenge to the feasibility at a high-volume center. This perspective discusses these limitations and propose plausible solutions to the conundrum. To make it widely applicable and feasible across the globe efforts should be directed to understand biology better, find novel solutions, and implement the lessons learned over decades from other sites.

View all citing articles on Scopus

View full text

Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis

Abstract

Objective

Methods

Results

Conclusion

Introduction

Section snippets

Data sources and search strategy

Literature search and selection of studies

Discussion

Conclusion

Declaration of interest

Funding information

Ethical approval

Informed consent

Am J Surg

Am J Surg

J Clin Epidemiol

J Clin Epidemiol

J Clin Epidemiol

J Clin Epidemiol

Med J Armed Forces India

Oral Oncol

J Oral Maxillofac Surg

Oral Oncol

Otolaryngol Clin N Am

Int J Radiat Oncol Biol Phys

Oral Oncol

Cancer statistics, 2018

CA Cancer J Clin

Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma

Cancer

The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections

Laryngoscope

Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection

Head Neck

Imaging of lymphadenopathy in the neck

Eur Radiol

Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography

Ann Surg

Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer

Ann Nucl Med

18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation

J Nucl Med

Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry

Head Neck

Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities

BMC Cancer

PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity

J Nucl Med

Preoperative evaluation of patients with primary head and neck cancer using dual-head ¹⁸fluorodeoxyglucose positron emission tomography

¹⁸F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation